Search

Your search keyword '"Tangen C"' showing total 189 results

Search Constraints

Start Over You searched for: Author "Tangen C" Remove constraint Author: "Tangen C"
189 results on '"Tangen C"'

Search Results

1. Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

2. Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217)

3. Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention Trial

5. INTACT (S/N1806): Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer—Toxicity Update on First 213 Patients

6. 1375P Intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC)

9. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

11. 1837P Assessing PSA

12. Re: Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

13. The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor

16. A - 26 AMPAR as a Sports Concussion Biomarker and Its Relationship to Neurocognitive Functioning in Collegiate Athletes

17. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

18. Shared heritability and functional enrichment across six solid cancers

19. Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)

20. A-118 SCAT5 Cognitive Screening Performance by Athlete Sex: Implications for Clinical Interpretation

22. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

23. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

24. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

25. Bone metabolism biomarkers (BMB) in hormone sensitive prostate cancer (HSPC): Results from SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) +/- orteronel

26. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

27. Exome sequencing of tumor samples from S1107 “Randomized phase II evaluation of tivantinib and tivantinib in combination with erlotinib in patients with papillary renal cell carcinoma (pRCC)”

30. Estrogen does not prevent dementia in women with ApoE-e4

33. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

39. Effect Of Vitamin E And Selenium On Rate Of Decline In FEV1: The Respiratory Ancillary Study To The Selenium And Vitamin E Cancer Prevention Trial (SELECT)

41. Effect Of Vitamin E And Selenium On Incidence Of Physician-Diagnosed COPD: The Selenium And Vitamin E Cancer Prevention Trial (SELECT)

43. Lack of Low-risk Pathologic Findings in SWOG 8794

49. Finasteride and High-Grade Prostate Cancer in the Prostate Cancer Prevention Trial

Catalog

Books, media, physical & digital resources